Cirrhosis in patients with rheumatoid arthritis receiving low dose methotrexate. 1994

G Chandran, and M J Ahern, and P D Hall, and R Geddes, and M D Smith, and W Hill, and J H Harley
Department of Medicine, Repatriation General Hospital, Daw Park, South Australia.

We describe three patients with RA who developed cirrhosis while taking low dose methotrexate (MTX). This report includes a review of the risk factors for cirrhosis occurring in association with MTX. Two of these patients were part of a prospective study to quantify changes in pericellular and total collagen in 76 patients with RA receiving low dose pulse MTX, giving a point prevalence of cirrhosis of 2.63%.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

G Chandran, and M J Ahern, and P D Hall, and R Geddes, and M D Smith, and W Hill, and J H Harley
December 1987, Arthritis and rheumatism,
G Chandran, and M J Ahern, and P D Hall, and R Geddes, and M D Smith, and W Hill, and J H Harley
January 1982, The Journal of rheumatology,
G Chandran, and M J Ahern, and P D Hall, and R Geddes, and M D Smith, and W Hill, and J H Harley
November 1997, The Journal of the Association of Physicians of India,
G Chandran, and M J Ahern, and P D Hall, and R Geddes, and M D Smith, and W Hill, and J H Harley
February 1989, Journal of pharmaceutical sciences,
G Chandran, and M J Ahern, and P D Hall, and R Geddes, and M D Smith, and W Hill, and J H Harley
March 1993, Arthritis and rheumatism,
G Chandran, and M J Ahern, and P D Hall, and R Geddes, and M D Smith, and W Hill, and J H Harley
August 1990, Annals of the rheumatic diseases,
G Chandran, and M J Ahern, and P D Hall, and R Geddes, and M D Smith, and W Hill, and J H Harley
February 1990, Arthritis and rheumatism,
G Chandran, and M J Ahern, and P D Hall, and R Geddes, and M D Smith, and W Hill, and J H Harley
December 2000, Postgraduate medical journal,
G Chandran, and M J Ahern, and P D Hall, and R Geddes, and M D Smith, and W Hill, and J H Harley
September 1986, Thorax,
G Chandran, and M J Ahern, and P D Hall, and R Geddes, and M D Smith, and W Hill, and J H Harley
June 1990, Ryumachi. [Rheumatism],
Copied contents to your clipboard!